Startups

Scientist 3, In Vivo Translational Imaging

Genentech · South San Francisco · On-site

← All jobs
About Genentech

Genentech discovers, develops, manufactures and commercializes treatments for patients with serious and life-threatening medical conditions. Backed by North Carolina Biotechnology Center.

About the role

Design, execute, and optimize in vivo preclinical imaging studies following approved ethical, compliance, and institutional safety standards. Operate and refine preclinical MRI protocols, applying quantitative methods to characterize anatomy, microstructure, physiology, and therapeutic treatment responses.

More about this role

The Opportunity

In the Department of Translational Imaging, you will drive preclinical and translational imaging research to help deliver life-changing healthcare solutions. You will work within a highly collaborative, multidisciplinary environment, moving seamlessly between in vivo experimentation, scanner operations (preclinical MRI/PET), quantitative analysis, and modern AI-enabled computational workflows to translate imaging data into therapeutic discoveries.

Design, execute, and optimize in vivo preclinical imaging studies following approved ethical, compliance, and institutional safety standards.

Operate and refine preclinical MRI protocols, applying quantitative methods to characterize anatomy, microstructure, physiology, and therapeutic treatment responses.

Support multimodal imaging studies by integrating data across nuclear imaging (PET/SPECT) and biodistribution workflows.

Develop and maintain robust, reproducible image-processing pipelines for registration, segmentation, quantitative feature extraction, and longitudinal analysis.

Build scalable, reproducible analysis code primarily in Python, executing workflows across High-Performance Computing (HPC) clusters...

Read the full posting on Genentech's site ↗

Build your edge while you search

Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.